Celgene, Mesoblast $45M Deal “Speaks Volumes” About Big Pharma’s Cell Therapy Plans, Says Pluristem Therapeutics

Posted: April 13th, 2015  |  Company/topic: Celgene
April 14, 2015By…

Mesoblast sells minority stake to Celgene for $44.4M

Posted: April 13th, 2015  |  Company/topic: Celgene
Celgene agreed to pay $44.4 million to acquire about a 4.5% stake in stem cell therapy developer Mesoblast, boosting the form -More- LentiKat's offers an unusual investment opportunity Lent…

Celgene buys into Mesoblast’s stem cell pipeline in regenerative med pact

Posted: April 13th, 2015  |  Company/topic: Celgene
Celgene has stepped up with a deal to buy a $45 million chunk of Mesoblast's stock at a premium price in exchange for a front row seat on the Australian biotech's stem cell pipeline and a preferred sp…

Mesoblast Shoots to a 4-Year High as Celgene Invests $45 Million

Posted: April 12th, 2015  |  Company/topic: Celgene
Celgene And Mesoblast Enter Into Equity Placement and Right of First Refusal Agreement To Certain Disease FieldsMELBOURNE, Australia and NEW YORK, April 12, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited…